Business
Press Release Aug 07 2023
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 07, 2023, titled "Completion of US FDA Post-marketing Adverse Drug Experience (PADE) inspection".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated August 07, 2023, titled \"Completion of US FDA Post-marketing Adverse Drug Experience (PADE) inspection\". View Attachment","length":334,"tagName":"div"}]